Skip to main content

Our Medicines Contact Us Careers

Americas

Argentina

Brazil

Canada

Chile

Colombia

Mexico

Peru

United States

Asia Pacific

Australia

China

Simplified Chinese

India

Japan

Korea

Korean

New Zealand

Singapore

Taiwan

Traditional Chinese

Thailand

Europe

Austria

German

Belgium

English Dutch French

Czech Republic

Czech

Denmark

Finland

France

French

Germany

German

Greece

Greek

Hungary

Ireland

Italy

Luxembourg

Netherlands

Norway

Poland

Poland

Portugal

Romania

Spain

Sweden

Switzerland

United Kingdom

Middle East

Israel

Hebrew

Saudi Arabia

Turkey

United Arab Emirates

Other

Other Markets

Distributor Markets

Our Medicines

Patients & Caregivers

Healthcare Providers

Medical education resources

Researchers & Partners

Our Therapy Areas

Our Stories

People

Collaborating with the Head and Neck Cancer community to help patients return to work

The Path to Progress: Research and Development Spotlight

Forging the Future with the University of Birmingham: The power of industry and academic PhD partnerships

The Path to Progress: Clinical Trials Spotlight

The Path to Progress: Regulatory Affairs and Medical Affairs Spotlight

The Path to Progress: Market Access Spotlight

The Path to Progress: Sales and Marketing Spotlight

Science

The future of cancer care: transformative innovation for all

Driving genetic data diversity in health research with Genes & Health

Reimagining the Future of Life Sciences

Exploring drug resistance in partnership with the University of Oxford

Transforming drug development using UK Biobank genetic and proteomic data

Accelerating the development of immuno-oncology services in the NHS

News & Perspectives

Our UK facility in the North West exemplifies sustainability innovation

C2C4C: A grand finish in Brussels

Putting Moreton on the map: How our R&D site in the North-West of England is harnessing local investment to become a global hub for innovation

Pioneering Solutions for a Greener Future

Celebrating 10 years of C2C4C

Driving a transformative approach to understanding menopause in the workplace

Squaring the impossible circle: Looking to a future of improved cancer patient experience and efficient care

Cancer Equals: UK wide research highlights differences in cancer care

Bristol Myers Squibb expands health equity grant initiatives to improve health outcomes

Guy Oliver appointed as General Manager for Bristol Myers Squibb UK and Ireland

A top 10 placing for BMS in the UK’s Best Workplaces 2024 List

Lung cancer experts address unwarranted variation in diagnosis and treatment

About Us

Our Mission

Our Principles

Responsibility

Partnering

Transparency

Grants, Giving & Corporate Sponsorship Support

UK Tax Strategy 2023

Inclusion & Diversity

Donations & Grants

Global Patient Week

Global Patient Week 2023

Sustainability

Doing Business with Us as a Supplier

Contact Us

Our Site at Chester

Our Site at Moreton

Our Site at Uxbridge

Life Sciences 2030

More than Guts: Inflammatory bowel disease podcast

Transforming cancer outcomes in the UK: clearing the backlog, improving capacity and building services for tomorrow

People and Business Resource Groups

Search

The Pathology of Plaque Psoriasis

Quick Links

Home
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Careers

Modern Slavery Act
Tax Policy Statement
Gender Pay Report
Employee Privacy Notice
Our Stories

Resources

Follow Us

Legal Notice
Privacy Policy
Pharmacovigilance Notice
Contact Us

21/06/24

© 2024

Bristol-Myers Squibb Company

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.